The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Pazopanib (Primary) ; Doxorubicin; Ifosfamide
- Indications Soft tissue sarcoma
- Focus Pharmacokinetics; Therapeutic Use
- 05 Apr 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 14 Dec 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Oct 2016 as per ClinicalTrials.gov record.
- 05 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.